Instapath Inc.
YC W19Houston, US · Founded 2017 · Delaware corporation · 6 employees · 1 known investors
Instapath develops rapid digital pathology microscopy platforms that enable cancer diagnosis from tissue samples in minutes rather than days. The technology serves pathology labs and healthcare providers to accelerate cancer diagnosis and reduce repeat biopsy procedures.
Founders & leadership· Y Combinator alumni (W19)
Investors · 1
Competitors · 3
by search overlapClarapath15 shared keywordsClarapath develops healthcare robotics, machine vision, and digital automation tools for hospitals to improve diagnostic sample processing and patient care. The company manufactures its products in-house at its New York facility with ISO 13485/GMP certification.
Mapquest12 shared keywordsProvider of geographical information systems and services; acquired by America Online.
mPATH Health8 shared keywords
Companies competing with Instapath Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$1.8MraisedSep 2019 · 20 investors · Other TechnologyRule 506(b)
▶$1.8MraisedSep 2019 · 20 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David TulmanExecutive Officer, Director
- David TulmanExecutive Officer, Director
- David TulmanExecutive Officer, Director
- David TulmanExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.